Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Merck Ord Shs MKGAF

Alternate Symbol(s):  MKKGY

Healthcare
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:MKGAF)

Athinia(TM) expands partnerships to include Tokyo Electron for real-time collaborative analytics of semiconductor fab equipment performance

PR Newswire July 11, 2023

Merck KGaA, Darmstadt, Germany, Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment in Biliary Tract Cancer

PR Newswire March 16, 2021

Merck KGaA, Darmstadt, Germany, to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 19 November 2020

PR Newswire November 13, 2020

Breakthrough Innovation in Cancer Care From EMD Serono Pipeline to Be Presented at ASCO 2020

PR Newswire May 13, 2020

Merck Invests in Expansion of Manufacturing Capacity for Biotech Medicines

Stockhouse Editorial March 28, 2019

Pivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

Stockhouse Editorial February 17, 2019

Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer

PR Newswire December 21, 2018

Merck and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer

Stockhouse Editorial December 21, 2018

Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer

PR Newswire November 19, 2018
View More News ››

Opinion & Analysis (OTCPK:MKGAF)

Investment in cell and gene therapies ramps up

The Life Sciences Report June 8, 2016

Investing in the future of cancer treatment (BMY)

Frank Curzio August 23, 2014
View More Opinion ››

Bullboard Posts (OTCPK:MKGAF)

Be the first to post on this bullboard.

Viva Gold Corp.

Viva Gold Corp.

Viva Gold Corp. is a Canada-based gold exploration and development company, The Company’s business is the acquisition ...
View More »